Literature DB >> 3858849

6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency.

E Beutler, W Kuhl, T Gelbart.   

Abstract

Partial deficiency of 6-phosphogluconolactonase (EC 3.1.1.31) of the erythrocytes was discovered as an autosomal dominant disorder. Hemolytic anemia occurred in an individual who had inherited both the gene for 6-phosphogluconolactonase deficiency and that for deficiency of a nonhemolytic variant of glucose-6-phosphate dehydrogenase (EC 1.1.1.49). It is proposed that the interaction of this hereditary erythrocyte abnormality with glucose-6-phosphate dehydrogenase deficiency may explain hemolysis in some other patients who have inherited polymorphic variants of glucose-6-phosphate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3858849      PMCID: PMC397891          DOI: 10.1073/pnas.82.11.3876

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  OXIDATIVE HEMOLYSIS AND ERYTHROCYTE METABOLISM IN HEREDITARY ACATALASIA.

Authors:  H S JACOB; S H INGBAR; J H JANDL
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

2.  New data on glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia. G6PD variants, and the association between enzyme deficiency and hemoglobins S.

Authors:  A P Gelpi; M C King
Journal:  Hum Hered       Date:  1977       Impact factor: 0.444

3.  Rat liver 6-phosphogluconolactonase: a low Km enzyme.

Authors:  P J Schofield; A Sols
Journal:  Biochem Biophys Res Commun       Date:  1976-08-23       Impact factor: 3.575

4.  Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease.

Authors:  E Beutler; C K Mathai; J E Smith
Journal:  Blood       Date:  1968-02       Impact factor: 22.113

5.  Continuous measurement of pentose phosphate pathway activity in erythrocytes. An ionization chamber method.

Authors:  W D Davidson; K R Tanaka
Journal:  J Lab Clin Med       Date:  1969-01

6.  Red cell NADP+ and NADPH in glucose-6-phosphate dehydrogenase deficiency.

Authors:  H N Kirkman; G D Gaetani; E H Clemons; C Mareni
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

7.  6-phosphogluconolactonase. Purification, properties and activities in various tissues.

Authors:  H P Bauer; T Srihari; J C Jochims; H W Hofer
Journal:  Eur J Biochem       Date:  1983-06-01

8.  Hemolytic anemia and G6PD deficiency.

Authors:  A Yoshida
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

9.  Haemoglobin disorders: a pattern for thalassaemia and haemoglobinopathies in Arabia.

Authors:  M A El-Hazmi
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

10.  The interference of leukocytes and platelets with measurement of clucose-6-phosphate dehydrogenase activity of erythrocytes with low activity variants of the enzyme.

Authors:  A Morelli; U Benatti; L Lenzerini; B Sparatore; F Salomino; E Melloni; M Michetti; S Pontremoli; A De Flora
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

View more
  6 in total

1.  A spectrophotometric assay for 6-phosphogluconolactonase involving the use of immobilized enzymes to prepare the labile 6-phosphoglucono-delta-lactone substrate.

Authors:  R D Moir; G B Stokes
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

2.  Proteomics Insights into the Gene Network of cis9, trans11-Conjugated Linoleic Acid Biosynthesis in Bovine Mammary Gland Epithelial Cells.

Authors:  Liying Peng; Ge Bai; Chunzheng Wang; Jianan Dong; Yongjun Liu; Zhe Sun; Yuguo Zhen; Guixin Qin; Xuefeng Zhang; Natnael Demelash; Tao Wang
Journal:  Animals (Basel)       Date:  2022-07-02       Impact factor: 3.231

Review 3.  The pentose phosphate pathway and cancer.

Authors:  Krushna C Patra; Nissim Hay
Journal:  Trends Biochem Sci       Date:  2014-07-15       Impact factor: 13.807

4.  Imaging 6-Phosphogluconolactonase Activity in Brain Tumors In Vivo Using Hyperpolarized δ-[1-13C]gluconolactone.

Authors:  Georgios Batsios; Céline Taglang; Peng Cao; Anne Marie Gillespie; Chloé Najac; Elavarasan Subramani; David M Wilson; Robert R Flavell; Peder E Z Larson; Sabrina M Ronen; Pavithra Viswanath
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

Review 5.  The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Authors:  Anna Stincone; Alessandro Prigione; Thorsten Cramer; Mirjam M C Wamelink; Kate Campbell; Eric Cheung; Viridiana Olin-Sandoval; Nana-Maria Grüning; Antje Krüger; Mohammad Tauqeer Alam; Markus A Keller; Michael Breitenbach; Kevin M Brindle; Joshua D Rabinowitz; Markus Ralser
Journal:  Biol Rev Camb Philos Soc       Date:  2014-09-22

6.  Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.

Authors:  Haymanti Bhanot; Ellen L Weisberg; Mamatha M Reddy; Atsushi Nonami; Donna Neuberg; Richard M Stone; Klaus Podar; Ravi Salgia; James D Griffin; Martin Sattler
Journal:  Oncotarget       Date:  2017-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.